Search - tctmd.com

Displaying 281 - 300 of 684

Sort: Relevancy | Date

Presentation TVT 2023

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Presenter: Azeem Latib

June 08, 2023

Presentation TVT 2023

Etiologies of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High volume Quaternary Care Hospital

Presenter: Lu Chen

June 08, 2023

Presentation THT 2023

TMVR Clinical Trials: Ready for Prime Time or Stuck in the Mud?

Presenter: Martin Leon

March 22, 2023

Presentation THT 2023

FDA Guidance on Meaningful Representation in Clinical Trials

Presenter: Bram Zuckerman

March 20, 2023

Presentation CTO 2023

How Do the Coronary Revascularization Clinical Trials Apply to the Patient in Front of Me?

Presenter: Ajay Kirtane

February 23, 2023

Presentation TCT 2022

Transcatheter Tricuspid Valve Replacement: Lessons Learned from Recent Clinical Trials

Presenter: Neil Fam

September 19, 2022

Presentation TCT 2022

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Presenter: Jonas Haener

September 19, 2022

Presentation TCT 2022

Cardiogenic Shock Trials: Defining the Clinical Need and Framing the Issues

Presenter: Navin Kapur

September 19, 2022

Presentation TCT 2022

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Presenter: Eric Secemsky

September 19, 2022

Presentation TCT 2022

Clinical Implications of RADIANCE II and Recent Renal Denervation Trials: A Clinician’s Perspective

Presenter: Patrick O'Gara

September 18, 2022

Presentation TCT 2022

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Presenter: C. Michael Gibson

September 18, 2022

Presentation TCT 2022

TCT 7: Invasive Versus Conservative Strategy in Elderly Patients With Non-ST Elevation Myocardial Infarction: A Meta-analysis of Randomized Controlled Trials

Presenter: Mahmoud Khalil

September 18, 2022

Presentation TCT 2022

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Presenter: Clyde Yancy

September 18, 2022

Presentation TCT 2022

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Presenter: Azeem Latib

September 18, 2022

Presentation TCT 2022

Ongoing Clinical Trials and the Future of LAAC

Presenter: Matthew Price

September 18, 2022

Presentation TCT 2022

Recent Clinical Trials & Registries: Update 2022

Presenter: Kolja Sievert

September 18, 2022

Presentation TCT 2022

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

Presenter: Alexandra J. Lansky

September 17, 2022

Presentation TCT 2022

TCT 14: A 30-day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) Post PCI in Brazil and Japan : SYNERGY Stent with Prasugrel Monotherapy (10 or 3.75 mg )

Presenter: Yoshinobu Onuma

September 17, 2022

Presentation TCT 2022

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Presenter: Naomi Fisher

September 17, 2022

Advertisement

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Etiologies of Exclusion Rates for Transcatheter Mitral and Tricuspid Valve Structural Heart Clinical Trials at a High volume Quaternary Care Hospital

TMVR Clinical Trials: Ready for Prime Time or Stuck in the Mud?

FDA Guidance on Meaningful Representation in Clinical Trials

How Do the Coronary Revascularization Clinical Trials Apply to the Patient in Front of Me?

Transcatheter Tricuspid Valve Replacement: Lessons Learned from Recent Clinical Trials

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Cardiogenic Shock Trials: Defining the Clinical Need and Framing the Issues

What Do the Clinical Trials Tell Us to Do in Intermediate-Risk PE?

Clinical Implications of RADIANCE II and Recent Renal Denervation Trials: A Clinician’s Perspective

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

TCT 7: Invasive Versus Conservative Strategy in Elderly Patients With Non-ST Elevation Myocardial Infarction: A Meta-analysis of Randomized Controlled Trials

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Ongoing Clinical Trials and the Future of LAAC

Recent Clinical Trials & Registries: Update 2022

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

TCT 14: A 30-day Pooled Analysis of Acetyl Salicylic Elimination Trials (ASET) Post PCI in Brazil and Japan : SYNERGY Stent with Prasugrel Monotherapy (10 or 3.75 mg )

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content